Cipla Rides High Amid US Market Shakeout

Cipla reports highest ever quarterly revenues in the US, a market that’s seeing lower “price compression” amid sell-offs, bankruptcies and a rebalancing of the supply chain. The firm’s portfolio has a “lot of steam” left to be unlocked and it’s also keeping an eye on the impact of the tornado-hit Pfizer site on supplies.

Strong Run In Q1 For Cipla Amid US Churn • Source: Shutterstock

Cipla Limited rang in strong earnings in the first quarter of fiscal 2024, lifted by robust growth across its key markets of India, the US and South Africa.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Generics Bulletin for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Business

More from Generics Bulletin